4.5 Article

Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease

Journal

FEBS LETTERS
Volume 582, Issue 2, Pages 359-364

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2007.12.035

Keywords

glucose transporters; tau; hyperphosphorylation; Alzheimer disease; O-GleNAcylation; hypoxia-inducible factor

Funding

  1. NIA NIH HHS [AG 027429, P30 AG 19610, R01 AG027429-02, P30 AG019610, R01 AG027429] Funding Source: Medline
  2. NATIONAL INSTITUTE ON AGING [P30AG019610, R01AG027429] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Brain glucose uptakelmetabolism is impaired in Alzheimer disease (AD). Here, we report that levels of the two major brain glucose transporters (GLUT1 and GLUT3) responsible for glucose uptake into neurons were decreased in AD brain. This decrease correlated to the decrease in O-GlcNAcylation, to the hyperphosphorylation of tau, and to the density of neurofibrillary tangles in human brains. We also found down-regulation of hypoxia-inducible factor 1, a major regulator of GLUT1 and GLUT3, in AD brain. These studies provide a possible mechanism by which GLUT1 and GLUT3 deficiency could cause impaired brain glucose uptake/metabolism and contribute to neurodegeneration via down-regulation of O-GlcNAcylation and hyperphosphorylation of tau in AD. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available